Lutetium Lu 177 dotatate is under clinical development by Advanced Accelerator Applications and currently in Phase II for Small-Cell Lung Cancer.

Aman Chauhan, MD, highlights an ongoing phase 2 trial exploring the combination of triapine, a radiation sensitizer, with ...

Called the Qinshan Nuclear Power Base plant, it has already produced its first batch of Lutetium-177 (Lu-177) medical ...

China's first commercial reactor device for the online irradiation production of isotopes was officially put into operation ...

Or it could be the last of the lanthanides - lutetium. After completing my PhD, I carried out postdoctoral research trying to make new organometallic compounds of the metallic elements with electrons ...

Get detailed information on Lutetium Lu 177 Dotatate, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

An organization representing Canada's public drug plans has come to a deal with a pharmaceutical company over a ...

Lutetium 177 dotatate showed activity and met the PFS end point in patients with surgery- or radiation-refractory grade 2/3 ...

Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify ...

Radiopharm Theranostics (ASX:RAD) has received approval from the Belberry Human Research Ethics Committee to commence the ...

Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify ...